ACE and hepatocellular carcinoma: While our study was underpowered to confirm whether serum DCP levels discriminate for postoperative cancer recurrence, a number of experiences, mostly from Asia, have clearly confirmed the usefulness of serum DCP as an HCC diagnostic as well as prognostic marker [3,16,24].